🇺🇸

Broad Market

· daily

US Material Events SEC 8-K Filings — August 17, 2026

The August 17, 2026, filing batch reveals a market dominated by transformative M&A and significant capital structure maneuvers, with several multi-billion-dollar deals reshaping the industrial, real estate, and technology landscapes. The merger of AvalonBay and Equity Residential into Vivmark ($70B EV) and Madison Air's $5.4B acquisition of ebm-papst signal a strong appetite for scale and synergies, while TTM Technologies' $1.1B deal and Fulcrum/Slate Medicines' reverse merger highlight sector-specific consolidation. A notable undercurrent is financial stress, with several companies (Prairie Operating, Phoenix Energy, Abundia Global) securing high-cost or restrictive debt amendments, and a wave of CFO transitions (Centene, Aon, Enovix) creating leadership uncertainty. Insider activity was sparse but negative in one key instance (LiveRamp's say-on-pay rejection), while capital raises via debt (AMD $4.75B, MasTec $650M) and equity (Dare Bioscience, Dermata) point to active balance sheet management. The overall sentiment is cautiously positive for large-cap strategic moves but bearish for smaller, cash-constrained firms.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 17, 2026

This digest covers 46 filings from August 17, 2026, dominated by a wave of corporate distress and strategic realignment. The most critical theme is a surge in insolvencies and defaults, with Pradhin Limited, Vivimed Labs, Simbhaoli Sugars, TV Vision, and Dharan Infra-EPC all undergoing CIRP, while Mangalam Drugs shows a prolonged 10-month bank default. Concurrently, a major consolidation is underway in the real estate and behavioral health sectors, highlighted by the $70B merger of AvalonBay and Equity Residential into Vivmark Residential, and Universal Health Services' acquisition of Talkspace. Several companies are also facing Nasdaq delisting pressures, including Dermata Therapeutics, Nexalin Technology, and Talkspace (post-acquisition). On the positive side, there is significant M&A activity in the industrial and infrastructure space, with Lloyds Engineering and Lloyds Enterprises acquiring controlling stakes in SISCOL, and Manipal Health Enterprises expanding its hospital network. The data reveals a bifurcated market: capital is flowing into strategic consolidations and growth acquisitions, while heavily indebted or operationally challenged companies are entering resolution processes.

46 high priority 46 total filings
· daily

US SEC Filings Daily Market Digest — August 17, 2026

Today's filings reveal a market bifurcated between aggressive M&A and capital markets activity and a wave of operational distress. Notable M&A includes TTM Technologies' $1.1B acquisition of Epiq Solutions and LogicMark's merger with Langham Project, while several companies (Wellgistics, Ming Shing, Cosan) show severe revenue declines or losses. Late filings (NT 10-Q) from M2i Global, FDCTECH, Duos, and IWAC signal potential accounting or operational issues. Insider activity is limited, but Dreamland's CEO increased her stake, and Cosan's CFO departure adds to its restructuring narrative. Capital allocation trends show a mix of warrant exercises (Dogness), convertible note raises (Wellgistics), and a SPAC IPO (Gravity Acquisition). Sector themes include a focus on liquidity and restructuring in energy/industrial, continued biotech volatility, and passive ETF dominance in 13F filings. Key catalysts include Centene's CFO transition, Interactive Strength's special meeting, and Bleichroeder's business combination vote.

17 high priority 33 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 17, 2026

The overnight filing period from August 16-17, 2026, reveals a market dominated by significant corporate actions, including a major $1.1B acquisition by TTM Technologies, a SPAC merger update for Bleichroeder Acquisition Corp. II, and a strategic restructuring at Cosan S.A. involving a NYSE delisting and asset spin-off. Financial distress is a prominent theme, with several companies (Wellgistics Health, Ming Shing Group, M2i Global) reporting sharp revenue declines and widening losses, while others like FDCTECH show dramatic turnarounds post-acquisition. Insider activity is mixed, with a significant insider purchase at Dreamland Ltd signaling confidence, contrasted by CEO termination at Tivic Health and CFO departures at Centene and Cosan. Capital allocation trends are defensive, with Cosan aggressively deleveraging and several companies raising cash through convertible notes and warrant exercises. The 13F filings reveal a strong institutional preference for large-cap tech and passive ETFs, with notable biotech concentration in some hedge fund portfolios. Overall, the market is bifurcated between companies executing transformative deals and those struggling with operational headwinds, creating both risks and opportunities for investors.

17 high priority 33 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 14, 2026

The August 14, 2026 batch of 50 filings reveals a market dominated by capital structure engineering and governance transitions, with a notable absence of broad operational growth trends. The most significant events are two transformative M&A deals—SpaceX's $60B stock acquisition of Anysphere (Cursor) and Skye Bioscience's reverse merger with Redx Pharma—which represent high-conviction, long-duration bets. Capital markets activity is intense, with five companies (Proficient Auto, Delek Logistics, EDAP TMS, Dyadic, Vuzix) raising over $600M combined, signaling a robust appetite for equity and convertible financing, particularly among smaller-cap and pre-revenue firms. However, this is counterbalanced by severe governance red flags: a sudden CFO departure at Beauty Health Co, a material earnings restatement at HCW Biologics, and a massive authorized share increase at Zoomcar, all pointing to underlying instability. Insider trading data is sparse, but the lack of insider buying in these capital raises suggests management is not aggressively signaling confidence. The period-over-period data available from Neumora and Lifeward shows a trend of improving operational efficiency (Neumora cut losses 18% YoY) but margin compression due to tariffs and FX (Lifeward gross margin down 300 bps), a theme likely to persist. The overall picture is one of strategic realignment and capital preservation, with investors needing to differentiate between companies executing disciplined transformations and those engaging in dilutive or opaque financial maneuvers.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 14, 2026

The August 14, 2026, digest reveals a market bifurcated between aggressive corporate restructuring and systemic distress. A dominant theme is the wave of corporate insolvencies in India, with several companies like BIL Vyapar, Bloom Dekor, and Electrotherm reporting deeply negative financials, qualified audit opinions, and ongoing CIRP proceedings, signaling a peak in the credit cycle's stress phase. Concurrently, there is significant M&A and capital allocation activity, highlighted by SpaceX's $60B all-stock acquisition of Cursor and Adani Energy's strategic transmission asset purchase, indicating that well-capitalized entities are deploying capital for long-term growth. A cluster of private credit and interval funds are conducting routine tender offers to provide liquidity, a neutral signal of standard operations. The delisting of Actinium Pharmaceuticals and Reed's Inc. underscores ongoing challenges for small-cap biotech and consumer goods companies in maintaining exchange listings. The most critical development is the sheer volume of insolvency-related filings, which suggests a concentrated risk event in the Indian corporate sector that warrants close monitoring for contagion effects. Portfolio-level patterns show a clear divergence: capital is flowing towards strategic, high-growth acquisitions while being withdrawn from distressed or non-core assets, creating a 'barbell' market environment.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 14, 2026

The August 14, 2026, filing batch reveals a market bifurcated between aggressive growth investments in AI, space, and critical minerals (e.g., Hancock Prospecting's $5.7B portfolio, Blue Sparrow's $10.3B tech-heavy fund) and a defensive, hedging posture among many institutional managers (e.g., Lonestar Capital's 53% put exposure, Yaupon Capital's $1.44B SPY put). Period-over-period data from operating companies shows a stark contrast: SaaS leader Intapp grew revenue 15% YoY but saw net losses widen 127%, while micro-cap SEATech and American Picture House remain cash-burning shells with no revenue. Insider activity is limited, but management changes at Lifeward (CFO departure) and Skye Bioscience (near-total dilution via reverse merger) signal significant governance shifts. Capital allocation trends are mixed, with Riverview Bancorp increasing buybacks while Edible Garden invests in growth. The most critical development is Skye Bioscience's acquisition of Redx Pharma, creating a new fibrosis leader with ~$125M in committed funding, though pre-deal shareholders face massive dilution. Portfolio-level patterns show a clear rotation toward SPACs and special situations (Shaolin Capital, Ghisallo Capital) and a defensive tilt with significant put buying on major indices, suggesting institutional caution on near-term market direction.

10 high priority 40 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 14, 2026

Overnight filings reveal a market with diverging signals: significant insider selling by major stakeholders in Silence Therapeutics and Sky Harbour Group contrasts with bullish insider buying in OppFi and Attovia Therapeutics, the latter seeing a director and Goldman Sachs collectively invest $17M. A notable pattern emerges with Balyasny Asset Management filing multiple passive 13G amendments, indicating a concentrated portfolio adjustment across several small-cap biotechs and SPACs. The most material operational update comes from Azul S.A., which reported record revenue but a sharp EBITDA decline and net loss due to surging fuel costs, highlighting severe margin compression in the airline sector. Meanwhile, the 21Shares Ethereum ETF reported a mixed quarter with staking rewards growth offset by significant unrealized losses from ether price declines. Institutional 13F filings from Desjardins, Firsthand Capital, and Oasis Management reveal varying strategies, with Oasis's large put options on QQQ signaling a bearish hedge on tech. Overall, the data points to cautious capital deployment, with insider selling for monetization and passive stake adjustments outweighing aggressive bullish bets.

23 high priority 27 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 13, 2026

This Material Events Monitor digest, covering 50 filings from August 13, 2026, reveals a market sharply divided between aggressive capital deployment and acute financial distress. A dominant theme is significant M&A and capital markets activity, led by Parker-Hannifin's $9.25B acquisition of Filtration Group and Global Net Lease's accretive $535M industrial portfolio purchase, signaling confidence in strategic growth. Concurrently, a wave of distressed financing is evident, with companies like Banzai, Lithium Americas, and Professional Diversity Network issuing highly dilutive or complex debt/equity instruments to address liquidity needs. Governance and accounting integrity are under the microscope, highlighted by Pelthos Therapeutics' material weakness restatement and several sudden, unexplained officer departures. While some firms like Opendoor are executing sophisticated, shareholder-friendly capital structure maneuvers, others are facing going-concern risks and auditor changes. The overall picture is one of bifurcation: well-capitalized firms are pursuing transformative deals, while a significant cohort is fighting for survival through complex and often dilutive financing.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 13, 2026

This digest covers 50 regulatory filings from August 13, 2026, dominated by distress and restructuring in Indian markets, alongside significant M&A activity in the US. Key themes include a wave of insolvencies (Cerebra, RCOM, Premier, Quadrant, Baron Infotech) and going-concern uncertainties (SAB Events, Leel Electricals), signaling a stressed credit environment. On the M&A front, two mega-deals closed: Parker-Hannifin's $9.25B acquisition of Filtration Group and Global Net Lease's $535M acquisition of Modiv Industrial, both immediately accretive. Insider activity was sparse, but notable was a promoter group entity increasing its stake in OBCL Limited by ~0.75% via open market purchases. Forward-looking statements highlight a catalyst-rich period, with several NCLT hearings and shareholder meetings scheduled in September 2026. The overall sentiment is bearish for distressed Indian entities and cautiously bullish for US industrial consolidation plays.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 13, 2026

The August 13, 2026 SEC filing batch reveals a market bifurcated between operational improvements and persistent financial stress. While several companies (Liftoff Mobile, Global Water Resources, Nuveen Global Cities REIT) posted strong YoY revenue and earnings growth, others (King Resources, Provectus Biopharmaceuticals) continue to burn cash with widening losses. Institutional 13F filings show a pronounced rotation into mega-cap tech and AI-related names, with notable new positions in Arm Holdings and Climb Bio, while hedge funds like Saba Capital trimmed passive stakes. Capital allocation trends highlight aggressive share repurchases at Nuveen Global Cities REIT despite net redemptions, and a shift toward debt-funded growth at Star Mountain. Insider activity is sparse, but the reduction in AQR's stake in Ultragenyx and Saba's cut in Voya Asia Pacific signal cautious sentiment. Forward-looking catalysts include upcoming earnings calls and potential FDA decisions, with the market closely watching guidance revisions and liquidity positions.

16 high priority 34 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 13, 2026

Overnight filings reveal a bifurcated market with aggressive growth stories in niche sectors (BBB Foods, Elmet Group) offset by deep value destruction in biotech and SPACs. A massive coordinated insider sell-off at Takeda Pharmaceutical ($7.5M+ across 10 executives) signals deep concern within the C-suite, while a contrarian insider buying spree at Hepion Pharmaceuticals ($725K) suggests a potential turnaround play. The most significant capital event is SoundHound AI's proposed acquisition of LivePerson, which could reshape the conversational AI landscape. Key period-over-period trends show revenue growth is not translating to profitability, with 4 out of 5 reporting companies showing widening net losses despite top-line expansion. The energy sector shows mixed signals with enCore Energy's uranium deliveries up 38.6% but extraction costs soaring, while the SPAC market shows continued distress with Newbury Street's net income collapsing 81.5%.

40 high priority 10 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 12, 2026

The August 12, 2026 filings reveal a market actively managing balance sheets through refinancing, capital raises, and strategic M&A, while corporate governance changes and restatements signal underlying stress. Key themes include liability management (Charter, American Airlines, Southwest), equity issuance for growth and liquidity (Ryman, Sky Harbour, ACRES), and transformative M&A (AEVEX, Modiv/GNL). Financial performance is mixed: OptimizeRx and Stem show revenue declines but margin improvements, while Crown Crafts and PubMatic show positive trends. Insider activity is limited, but notable director departures at SPAR Group and a CFO change at BitGo warrant attention. Forward-looking guidance is largely reaffirmed, with key catalysts including ArriVent's Phase 3 data and AEVEX's acquisition close. Overall, the digest points to a cautious but active corporate environment, with selective opportunities in companies demonstrating operational resilience and strategic clarity.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 12, 2026

The August 12, 2026 digest is dominated by a wave of corporate distress and restructuring, with 12 filings related to insolvency, bankruptcy, or delisting, and 20 filings involving mergers, acquisitions, or business combinations. The most critical development is the convergence of multiple high-risk events: Simbhaoli Sugars' deepening insolvency with an adverse audit opinion, the forced delisting of CID Holdco (Dot Ai) and Agriculture & Natural Solutions Acquisition Corp, and the Nasdaq non-compliance of Generation Income Properties. On the M&A front, the completion of Modiv Industrial's merger with Global Net Lease and the SEC effectiveness of the Inflection Point Acquisition Corp. V / GOWell business combination signal active SPAC consolidation. A notable trend is the aggressive expansion of Indian companies into new subsidiaries and joint ventures, with 10 filings detailing new incorporations or stake acquisitions, often in early-stage entities with nil turnover. Period-over-period data reveals a stark contrast: Lenskart Solutions posted strong 30.6% YoY revenue growth, while Sudarshan Chemical Industries saw a 27.5% YoY revenue decline, and Stem Inc. reported a 12% YoY revenue drop. The overall sentiment is heavily negative, with a high concentration of risk flags in the Indian corporate insolvency space and US-listed companies facing delisting, but select opportunities exist in the turnaround of Nova Iron & Steel and the high-growth acquisition by UVS Hospitality.

50 high priority 50 total filings
· daily

US SEC Filings Daily Market Digest — August 12, 2026

The August 12, 2026, filing set reveals a market bifurcated between high-growth, cash-burning companies and stable, income-oriented institutions. A dominant theme is the aggressive capital expenditure and debt-fueled expansion in the tech and infrastructure sectors, exemplified by WhiteFiber's 54.5% revenue surge but 51% cash decline, and Applied Aerospace's 47.4% revenue growth offset by a $154M net loss from IPO costs. Conversely, the healthcare sector shows a stark contrast between commercial-stage success (Protalix's $22.1M net income swing) and pre-revenue cash burn (Onconetix's going-concern risk). The financial filings are dominated by passive 13F snapshots, revealing a broad institutional preference for mega-cap tech and fixed-income ETFs, with notable exceptions like Condor Capital's $1.33B ETF-heavy portfolio and Marathon Trading's aggressive use of options for hedging and speculation. Key period-over-period trends include margin compression in mature industrials (Utah Medical Products, Air Industries Group) and a shift toward shareholder returns, with Arbutus planning a $230M buyback from a litigation settlement. The most critical developments are the $510M dilutive acquisition by Ming Shing Group, the $225M capital raise by Altimmune for a Phase 3 trial, and the securities class action lawsuit against Datavault AI, all of which carry significant market implications for their respective sectors.

10 high priority 40 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 12, 2026

Overnight filings reveal a market bifurcated between aggressive growth investment and insider profit-taking. Key themes include a surge in director-level stock awards at Nu Holdings and STEM, signaling long-term alignment, contrasted with substantial insider selling at LandBridge Co LLC ($93.8M) and Charles Schwab ($5.01M). Earnings reports from Amcor and BETA Technologies show strong top-line growth driven by M&A and defense contracts, but with widening losses and cautious forward guidance, creating a mixed sentiment. Institutional filings from AI-Squared and Westpac highlight a continued focus on mega-cap tech and Chinese ADRs. The most actionable signals center on the transformative Berry acquisition at Amcor, the strategic investment in GCL Global's gaming subsidiary, and the complete exit of Goldman Sachs from Cantaloupe, which may indicate a loss of confidence in the stock.

34 high priority 16 medium 50 total filings
· daily

US Material Events SEC 8-K Filings — August 11, 2026

This batch of 50 filings reveals a market bifurcated between aggressive capital deployment and acute financial distress. The most significant themes are a surge in M&A and strategic acquisitions (IES Holdings, National CineMedia, Ferguson Enterprises) alongside a wave of refinancing and liability management (Tyson Foods, Griffon, Superior Group). Conversely, several companies are in severe distress, with BioXcel Therapeutics facing an 11-day deadline to avoid default and JBS N.V. reporting a swing to a net loss despite higher sales. Leadership transitions are widespread, with notable CEO successions at ConocoPhillips and B&G Foods, while insider selling patterns are absent from the data. Capital allocation is polarized; some firms are raising debt for growth (Arbor Realty Trust) while others are pausing shareholder returns to de-lever (National CineMedia). The overall picture is one of a market where strong balance sheets are being used offensively, while weaker players are fighting for survival, creating a clear 'haves vs. have-nots' dynamic.

50 high priority 50 total filings
· daily

Global High-Priority Regulatory Events — August 11, 2026

This digest covers 48 filings, predominantly from Indian markets, with a heavy concentration on insolvency proceedings (Baron Infotech, Tricom Fruit Products, KSS Ltd, Punj Lloyd, Simbhaoli Sugars, BIL Vyapar) and merger/acquisition activity (Pudumjee Paper, Emrock, Infibeam Avenues, Austin Engineering, GEM Enviro, CAMS, TARC, PI Industries, Aether Holdings). A clear theme of financial distress is evident, with multiple companies under Corporate Insolvency Resolution Process (CIRP) and reporting prolonged losses, negative reserves, and asset disposals. On the M&A front, we see a mix of strategic acquisitions (e.g., Infonative Solutions acquiring an AI edtech firm, GEM Enviro investing in solar energy) and related-party transactions (e.g., Duos Technologies selling a subsidiary to its interim CFO's entity). The most critical developments include the Supreme Court upholding Simbhaoli Sugars' insolvency, the NYSE delisting of Valens Semiconductor warrants, and the completion of Katapult Holdings' transformative all-stock merger creating a $4B+ revenue entity. Period-over-period trends show a stark divergence: revenue growth in some (TARC +187% YoY, Infibeam Avenues +119% YoY) contrasts with sharp declines in others (PI Industries -10.4% YoY, P.H. Capital revenue collapse). Insider activity is limited, but the Pasupati Fincap promoter's stake sale triggering an open offer is a notable signal. The overall market implication is a bifurcated environment where well-capitalized companies pursue growth via M&A while distressed entities face prolonged resolution processes.

48 high priority 48 total filings
· daily

US SEC Filings Daily Market Digest — August 11, 2026

The August 11, 2026 filing batch reveals a bifurcated market: strong growth in aerospace/defense and select industrials (Astronics, RBC Bearings) contrasts with margin pressure and cash burn in small-cap tech and biotech (Energy Focus, Inhibikase, Momentus). Institutional 13F filings show a defensive tilt toward ETFs, gold, and fixed income, with notable put options on major indices (All Terrain, Ninepoint) and continued interest in digital assets (Horizon Kinetics, Maripau). Insider activity is limited, but Frazier Life Sciences' post-IPO purchases in Attovia signal conviction. Key themes include AI-driven infrastructure demand (Solstice/Element deal), SPACs still searching for targets (Jaws Mustang, Rithm), and shareholder dilution concerns (Tron, Inhibikase).

16 high priority 34 medium 50 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 11, 2026

This morning's 50 filings present a bifurcated market landscape. A dominant theme is the concentrated, passive accumulation of shares in a single micro-cap, Park Ha Biological Technology, by six separate entities, collectively amassing over 56% of the diluted float, signaling a potential strategic play or a prelude to a corporate action. This is contrasted by significant insider selling, with a director at Spyre Therapeutics cashing out over $1M in a 10b5-1 plan and a 10% owner at Ramaco Resources liquidating a $4.8M stake. The healthcare sector shows a mixed picture: while Aptevo Therapeutics saw broad-based insider option exercises (a neutral-to-bullish signal of confidence), a director at Bausch & Lomb sold shares. On the capital allocation front, the Apollo-managed funds disclosed massive, stable stakes in Phoenix Education (69.1%) and Community Health Systems (8.4%), indicating a long-term, hands-off approach. The most critical development is the complete change of control at Abits Group, where the CEO sold his 47% voting stake, creating a binary catalyst tied to a future business acquisition. Overall, the data suggests a market where large institutional players are making strategic bets in small-cap biotech and distressed sectors, while insiders in high-growth and cyclical names are taking profits.

28 high priority 22 medium 50 total filings